Biotechnology Industry Overview
The biotechnology market is consolidated and features key players like Johnson & Johnson, Roche Holdings AG, and Novartis International. Market participants strategically leverage partnerships and acquisitions to bolster their product portfolios and establish a sustainable competitive edge.
• April 2024 - Merck, known as MSD, outside of the United States and Canada, and North Carolina Agricultural and Technical State University announced the Merck Biotechnology Learning Center opening at Gateway Research Park in Greensboro, North Carolina. The center is a 4,025-square-foot facility with classroom space, a process laboratory, and advanced biopharmaceutical manufacturing equipment.
• April 2024 - Boston Micro Fabrication (BMF) established a business headquartered in San Diego to develop and commercialize 3D BioChips by cultivating large-scale tissues in vitro to help accelerate new drug and cosmetic development. The company has introduced the BMF Biotechnology Inc. business unit to support better the use of highly precise microfluidic solutions in advanced drug development, pharmaceutical, and cosmetic research. BMF Biotechnology Inc. is expected to leverage BMF's Projection Micro Stereolithography (PµSL) 3D printing technology.
Biotechnology Market Leaders
-
Johnson & Johnson
-
Roche Holdings AG
-
Novartis International
-
Amgen Inc.
-
Gilead Science Inc.
- *Disclaimer: Major Players sorted in no particular order